Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Aim of the BETAPATH study is to evaluate whether the use of a personal digital assistant
(PDA) can improve the adherence of Multiple Sclerosis patients to a therapy with Betaseron.
The Personal digital assistant PDA functions as an electronic diary and as an injection
reminder.